A Randomized Clinical Trial of Cognitive Behavior Therapy (CBT) and Pharmacotherapy for Major Depressive Disorder
Phase 1
Completed
- Conditions
- There was no harm for subjects.Cognitive Behavior Therapy,Pharmachotherapy,Major Depressive Disorder
- Registration Number
- TCTR20200903003
- Lead Sponsor
- one
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Diagnosed patienst with major depressive disorders
With mild to moderate severity
With single episode
Duration of illness less then 6 months
With read, write and understand ability
Exclusion Criteria
Patients other than MDD were excluded
Patients with comorbid illness were excluded
With multiples episodes
More than 6 months duration of illness
MDD with severe rage
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Therapeutic outcomes After 3/4 months Depression, Anxiety, Stress Scale, Cognitive Distortion Scale, Subjective Well-being Scale
- Secondary Outcome Measures
Name Time Method Therapeutic alliance and transference after 3/4 months Therapeutic Alliance Scale and Transference Scale